基于密切值法的国内外医药制造企业技术创新能力对比研究

Technology Innovation Capacity of pharmaceutical manufacturing enterprises at China and abroad based on osculating value method

摘要:

医药制造企业的发展前景与战略方向,与其技术创新能力密切相关。本文以专利为切入点,建立技术创新立项、质量、效率三大维度共11项细化指标,采用密切值法对国内外医药行业创新实力进行对比与排序。实证研究得出,近年我国医药行业专利数量稳步增长,但增速后劲有限,高质量技术创新较少,团队合作力度尚待提升。

Abstract:

The development prospects and strategic directions of pharmaceutical manufacturing companies are closely related to their technological innovation capabilities. Taking patent as the entry point, this article establishes 11 refinement indexes in the three dimensions of technological innovation project establishment, quality and efficiency, and uses the close value method to compare and rank innovation strengths of domestic and foreign pharmaceutical industries. Empirical studies have concluded that the number of patents in the pharmaceutical industry in China has steadily increased in recent years, but the growth momentum is limited, there is less high-quality technology innovation, and team cooperation needs to be improved.